AI and the future of e-health
About this episode
This episode explores the impact of AI on e-health and pharmaceuticals, featuring insights from industry experts.
In this episode, we dive into the future of e-health and pharmaceuticals. Kertti Merimaa from Nortal shares how AI is already transforming healthcare through diagnostics, clinical decision support, and predictive tools, while also dispelling common myths about AI in medicine. Jason Grenfell-Gardner, CEO of J. Molner Company, explains how Estonia became a base for pharmaceutical innovation and why fixing fragile drug supply chains is just as critical as breakthrough therapies.
People in this episode
Guests: Kertti Merimaa, Jason Grenfell-Gardner
Topics covered
- e-health
- AI in healthcare
- pharmaceutical innovation
- drug supply chains
- diagnostics
- clinical decision support
Keywords
- AI
- e-health
- healthcare
- pharmaceuticals
- diagnostics
- clinical decision support
- drug supply chains
Mentioned in this episode
Organizations: Nortal, J. Molner Company
Places: Estonia
More episodes of The Art of Digitalisation
- Fixing regulation to unlock innovation
- Cybersecurity, phishing, and digital resilience
- Rethinking learning in the age of AI
- How digital systems make business easier
- Insights for the UK’s eID debate from Estonian experience
- Cyber command: defending a digital society
Explore listener stats, chart rankings, contacts and more on the The Art of Digitalisation podcast page.